News release

Mexico City - Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced a grant through the Apotex Global Health Access Fund to Vida y Familia México, I.A.P. ("VIFAC") to support programs that promote maternal and child health and address health disparities.

Building on Apotex's legacy of giving, including Apotex's global medicine donation program, the Apotex Global Health Access Fund focuses on addressing unequal access to care and low health literacy within communities where there are poor social determinants of health. Apotex has had a presence in Mexico since 1996.

VIFAC is the third Apotex Global Health Access Fund grant recipient, and the first in Mexico. The organization will receive $100,000 (~1,400,000 MXN) annually over the next three years to support their comprehensive maternal and child health services, aiming to improve health outcomes and address social determinants of health.

"We are thrilled to announce this grant to Vida y Familia, which underscores our commitment to addressing health disparities," said Alok Kanti, President, Apotex International. "By supporting organizations like VIFAC, we aim to make positively impact maternal and child health and the well-being of families, supporting them on their health journeys."

"We are incredibly grateful to Apotex for their commitment to our mission of improving the lives of mothers and children in need," said Gabriela Vilchis, General Director of VIFAC. "This support will help us expand our reach and enhance the services that we provide in helping reduce maternal and infant mortality in Mexico."

In its inaugural year, the Apotex Global Health Access Fund focuses on funding maternal health programs in Canada, the United States, India, and Mexico with an annual budget of $1 million.  

For more information about Vida y Familia México, I.A.P., please visit www.vifac.org

About Apotex

Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions. Learn more about us at www.apotex.com.